Abstract
Purpose
The aim of the present study was to compare the clinical effect of flaxseed and hesperidin alone and with combination in patients with metabolic syndrome. Number of participants with treated metabolic syndrome was assessed as a primary end point.
Methods
In this 12-week randomized controlled trial, ninety-eight patients with metabolic syndrome randomly assigned to receive either whole flaxseed powder (30 g/day), or hesperidin (1 g/day), or combination of 30 g flaxseed and 1 g hesperidin or no supplement while adhering a lifestyle modification program.
Results
In comparison to control group, systolic blood pressure (− 5.68 vs. − 2.91 mmHg, P = 0.041) and serum concentrations of triglyceride (− 50.06 vs. 3.87 mg/dL, P = 0.033) in hesperidin group showed a significant reduction over 12 weeks of intervention. Comparison of the results of flaxseed group with the control group showed a significant improvement in serum concentrations of triglyceride (− 66 vs. 3.87 mg/dL, P = 0.028), insulin (− 4.27 vs. − 2.51 mU/L, P = 0.003) and accordingly insulin resistance (− 1.19 vs. − 0.76, P = 0.005) and sensitivity (0.03 vs. 0.01, P = 0.022) indices in flaxseed group. Combination of flaxseed and hesperidin improved three of five metabolic syndrome components including serum concentrations of triglyceride, glucose and systolic blood pressure as compared to placebo. Interestingly, co-administration of flaxseed and hesperidin with 77.3% reduction in the prevalence of defined metabolic syndrome was revealed to be most effective in controlling the metabolic syndrome, after which the group of flaxseed with 76% reduction and hesperidin group with 54.5% reduction were ranked second and third, respectively.
Conclusions
It can be concluded that co-administration of flaxseed and hesperidin appears to be superior to either supplementation alone on metabolic syndrome treatment, while the effects of flaxseed are stronger than hesperidin supplementation.
Similar content being viewed by others
References
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17):2735–2752
Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F (2006) High prevalence of the metabolic syndrome in Iranian adolescents. Obesity 14(3):377–382
Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003) Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61(1):29–37
Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ (2004) Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol 44(3):720–732
Power M, Pratley R (2011) Alternative and complementary treatments for metabolic syndrome. Curr DiabRep 11(3):173–178
Graf BL, Raskin I, Cefalu WT, Ribnicky DM (2010) Plant-derived therapeutics for the treatment of metabolic syndrome. Curr Opin Investig Drugs (London, England: 2000) 11(10):1107
Ehteshami M, Shakerhosseini R, Sedaghat F, Hedayati M, Eini-Zinab H, Hekmatdoost A (2018) The effect of gluten free diet on components of metabolic syndrome: a randomized clinical trial. Asian Pac J Cancer Prev APJCP 19(10):2979–2984. https://doi.org/10.22034/apjcp.2018.19.10.2979
Hekmatdoost A, Mirmiran P, Hosseini-Esfahani F, Azizi F (2011) Dietary fatty acid composition and metabolic syndrome in Tehranian adults. Nutrition 27(10):1002–1007. https://doi.org/10.1016/j.nut.2010.11.004
Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108(13):1546–1551
Finicelli M, Squillaro T, Di Cristo F, Di Salle A, Melone MAB, Galderisi U, Peluso G (2019) Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives. J Cell Physiol 234(5):5807–5826. https://doi.org/10.1002/jcp.27506
Sohrab G, Ebrahimof S, Hosseinpour-Niazi S, Yuzbashian E, Mirmiran P, Azizi F (2018) Association of dietary intakes of total polyphenol and its subclasses with the risk of metabolic syndrome: tehran lipid and glucose study. Metab Syndr Relat Disord 16(6):274–281. https://doi.org/10.1089/met.2017.0140
Selvamuthukumaran M, Boobalan MS, Shi J (2017) Bioactive components in citrus fruits and their health benefits. In: Phytochemicals in citrus: applications in functional foods
Assini JM, Mulvihill EE, Huff MW (2013) Citrus flavonoids and lipid metabolism. Curr Opin Lipidol 24(1):34–40. https://doi.org/10.1097/MOL.0b013e32835c07fd
Sekgala MD, McHiza ZJ, Parker WA, Monyeki KD (2018) Dietary fiber intake and metabolic syndrome risk factors among young South African Adults. Nutrients. https://doi.org/10.3390/nu10040504
Chen JP, Chen GC, Wang XP, Qin L, Bai Y (2017) Dietary fiber and metabolic syndrome: a meta-analysis and review of related mechanisms. Nutrients. https://doi.org/10.3390/nu10010024
Poudyal H, Panchal SK, Diwan V, Brown L (2011) Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 50(4):372–387. https://doi.org/10.1016/j.plipres.2011.06.003
Ganorkar P, Jain R (2013) Flaxseed–a nutritional punch. Int Food Res J 20(2):519–525
Morris DH (2007) Flax: A health and nutrition primer. Flax Council of Canada
Hall C, Tulbek MC, Xu Y (2006) Flaxseed. Adv Food Nutr Res 51:1–97
Homayouni F, Haidari F, Hedayati M, Zakerkish M, Ahmadi K (2017) Hesperidin supplementation alleviates oxidative DNA damage and lipid peroxidation in type 2 diabetes: a randomized double-blind placebo-controlled clinical trial. Phytother Res PTR 31(10):1539–1545. https://doi.org/10.1002/ptr.5881
Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res (New York, NY) 33(5):367–375. https://doi.org/10.1016/j.nutres.2013.02.012
Constans J, Bennetau-Pelissero C, Martin JF, Rock E, Mazur A, Bedel A, Morand C, Berard AM (2015) Marked antioxidant effect of orange juice intake and its phytomicronutrients in a preliminary randomized cross-over trial on mild hypercholesterolemic men. Clin Nutr (Edinburgh, Scotland) 34(6):1093–1100. https://doi.org/10.1016/j.clnu.2014.12.016
Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Stoecker BJ, Arjmandi BH (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87(4):1527–1532. https://doi.org/10.1210/jcem.87.4.8374
Homayouni F, Haidari F, Hedayati M, Zakerkish M, Ahmadi K (2018) Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial. Phytother Res PTR 32(6):1073–1079. https://doi.org/10.1002/ptr.6046
Machado AM, de Paula H, Cardoso LD, Costa NM (2015) Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents. Nutrition (Burbank, Los Angeles County, Calif) 31(1):90–96. https://doi.org/10.1016/j.nut.2014.05.002
Kim JY, Jung KJ, Choi JS, Chung HY (2006) Modulation of the age-related nuclear factor-κB (NF-κB) pathway by hesperetin. Aging Cell 5(5):401–411
Expert Panel on Detection E (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486
Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A (2016) Flaxseed supplementation in metabolic syndrome management: a pilot randomized, open-labeled, controlled study. Phytother Res 30(8):1339–1344
Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA (2000) AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102(18):2284–2299
Kelishadi R, Rabiei K, Khosravi A, Famouri F, Sadeghi M, Rouhafza H, Shirani S (2001) Assessment of physical activity of adolescents in Isfahan. J Shahrekord Univ Med Sci 3(2):55–66
Pritchett AM, Foreyt JP, Mann DL (2005) Treatment of the metabolic syndrome: the impact of lifestyle modification. Cur Atheroscler Rep 7(2):95–102
Wu H, Pan A, Yu Z, Qi Q, Lu L, Zhang G, Yu D, Zong G, Zhou Y, Chen X (2010) Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome–4. J Nutr 140(11):1937–1942
Mulvihill EE, Huff WM (2012) Citrus flavonoids and the prevention of atherosclerosis. Cardiovasc Haematol Disord Drug Targets Form Curr Drug Targets Cardiovasc Hematol Disord 12(2):84–91
Miwa Y, Mitsuzumi H, Sunayama T, Yamada M, Okada K, Kubota M, Chaen H, Mishima Y, Kibata M (2005) Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J Nutr Sci Vitaminol 51(6):460–470
Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piché LA, Serratore P (2000) HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72(5):1095–1100
Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jäkel M, Trautwein EA (2010) The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women–3. J Nutr 140(9):1615–1620
Duval C, Müller M, Kersten S (2007) PPARα and dyslipidemia. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1771(8):961–971
Torkan M, Entezari MH, Siavash M (2015) Effect of flaxseed on blood lipid level in hyperlipidemic patients. Rev Recent Clin Trials 10(1):61–67
Akrami A, Nikaein F, Babajafari S, Faghih S, Yarmohammadi H (2018) Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome. J Clinical Lipidol 12(1):70–77. https://doi.org/10.1016/j.jacl.2017.11.004
Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, Sun SZ (2008) Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99(6):1301–1309. https://doi.org/10.1017/s0007114507871649
Tai CC, Ding ST (2010) N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 21(5):357–363
Murase T, Aoki M, Tokimitsu I (2005) Supplementation with α-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of β-oxidation in Zucker fatty rats. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1733(2):224–231
Tapia G, Valenzuela R, Espinosa A, Romanque P, Dossi C, Gonzalez-Mañán D, Videla LA, D'espessailles A (2014) N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation. Mol Nutr Food Res 58(6):1333–1341
Akiyama S, Katsumata S-i, Suzuki K, Ishimi Y, Wu J, Uehara M (2009) Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J Clin Biochem Nutr 46(1):87–92
Akiyama S, Katsumata S-i, Suzuki K, Nakaya Y, Ishimi Y, Uehara M (2009) Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci Biotechnol Biochem 73(12):2779–2782
Jung UJ, Lee M-K, Jeong K-S, Choi M-S (2004) The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 134(10):2499–2503
Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM (2012) Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Compl 26(6):483–490
Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, Quon MJ (2011) Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab 96(5):E782–792. https://doi.org/10.1210/jc.2010-2879
Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res 33(5):367–375
Morisset A-S, Lemieux S, Veilleux A, Bergeron J, Weisnagel SJ, Tchernof A (2009) Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr 102(2):195–200
Au MM, Goff HD, Kisch JA, Coulson A, Wright AJ (2013) Effects of soy-soluble fiber and flaxseed gum on the glycemic and insulinemic responses to glucose solutions and dairy products in healthy adult males. J Am Coll Nutr 32(2):98–100
Hallund J, Tetens I, Bügel S, Tholstrup T, Bruun JM (2008) The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 18(7):497–502
Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, Wang Y, Gu W, Zhang X, Chen X (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2(11):e1148
Taghizadeh M, Jamilian M, Mazloomi M, Sanami M, Asemi Z (2016) A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes. J Clin Lipidol 10(2):386–393
García-López S, Arriaga REV, Medina ON, López CPR, Figueroa-Valverde L, Cervera EG, Skidmore OM, Rosas-Nexticapa M (2016) One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome. J Pediatr Endocrinol Metab 29(10):1143–1150
Barre DE, Mizier-Barre KA, Griscti O, Hafez K (2008) High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. J Oleo Sci 57(5):269–273
Mohammadi-Sartang M, Sohrabi Z, Barati-Boldaji R, Raeisi-Dehkordi H, Mazloom Z (2018) Flaxseed supplementation on glucose control and insulin sensitivity: a systematic review and meta-analysis of 25 randomized, placebo-controlled trials. Nutr Rev 76(2):125–139. https://doi.org/10.1093/nutrit/nux052
Dodin S, Lemay A, Jacques H, Legare F, Forest J-C, Masse B (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90(3):1390–1397
Yamamoto M, Suzuki A, Hase T (2008) Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol 54(1):95–98
Ikemura M, Sasaki Y, Giddings JC, Yamamoto J (2012) Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res 26(9):1272–1277
Yamamoto M, Jokura H, Hashizume K, Ominami H, Shibuya Y, Suzuki A, Hase T, Shimotoyodome A (2013) Hesperidin metabolite hesperetin-7-O-glucuronide, but not hesperetin-3′-O-glucuronide, exerts hypotensive, vasodilatory, and anti-inflammatory activities. Food Funct 4(9):1346–1351
Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, Mazur A (2010) Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 93(1):73–80
Berry EM, Hirsch J (1986) Does dietary linolenic acid influence blood pressure? Am J Clin Nutr 44(3):336–340
Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fitó M, Salas-Salvadó J, Martínez-González MA, Aros F, Lamuela-Raventós RM (2014) Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin Nutr 33(1):90–97
Wilmsen PK, Spada DS, Salvador M (2005) Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 53(12):4757–4761
Kasote D (2013) Flaxseed phenolics as natural antioxidants. Int Food Res J 20(1):27
Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HHM, Martínez JA (2010) Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition (Burbank, Los Angeles County, Calif) 26(5):534–541
Li C, Schluesener H (2017) Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr 57(3):613–631. https://doi.org/10.1080/10408398.2014.906382
Acknowledgements
This study is related to the project No. 1397/61463 from Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran. We also appreciate the “Student Research Committee” and “Research & Technology Chancellor” in Shahid Beheshti University of Medical Sciences for their financial support of this study.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare there is no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yari, Z., Cheraghpour, M. & Hekmatdoost, A. Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial. Eur J Nutr 60, 287–298 (2021). https://doi.org/10.1007/s00394-020-02246-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-020-02246-9